TELA Bio, Inc. (TELA)


+0.25 (+3.52%)
Symbol TELA
Price $7.36
Beta 1.592
Volume Avg. 0.06M
Market Cap 107.144M
Shares () -
52 Week Range 5.15-16.25
1y Target Est -
DCF Unlevered TELA DCF ->
DCF Levered TELA LDCF ->
ROE -155.13% Strong Sell
ROA -65.04% Strong Sell
Operating Margin -
Debt / Equity 451.45% Strong Buy
P/E -
P/B 10.66 Strong Buy


Consensus EPS

Upgrades & Downgrades

Latest TELA news

Mr. Antony Koblish
Medical Devices
NASDAQ Global Market

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. The company markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.